Condition (MeSH)
Lung Abscess
ClinicalTrials.gov lists 7 trials for Lung Abscess or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 7 trials are tagged with Lung Abscess itself; the rest are tagged with a narrower condition beneath it.
When did Lung Abscess trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2024 | 2 |
| 2013 | 1 |
| 2010 | 1 |
| 2001 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Lung Abscess trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Not applicable | 2 |
| Observational | 4 |
How many Lung Abscess trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Lung Abscess trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Bayer | 1 |
| ChromX Health | 1 |
| Pfizer | 1 |
Which serious adverse events do Lung Abscess trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Respiratory failure | 5 | 1 |
| Chronic obstructive pulmonary disease | 3 | 1 |
| Asphyxia | 2 | 1 |
| Disease progression | 2 | 1 |
| Disseminated intravascular coagulation | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Lung Abscess? (11)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Surgical intervention for congenital pulmonary airway malformation (CPAM) patients with preoperative pneumonia and abscess formation: "open versus thoracoscopic lobectomy". | Pediatric surgery international | 2016 | Yes |
| Ultrasound in peripheral pulmonary air-fluid lesions. Color Doppler imaging as an aid in differentiating empyema and abscess. | Chest | 2009 | Yes |
| Percutaneous drainage of infected and noninfected thoracic fluid collections. | Journal of thoracic imaging | 1987 | Yes |
| An unusual neonatal case presentation: Streptococcus pneumoniae pneumonia with abscess and pneumatocele formation. | Journal of perinatology : official journal of the California Perinatal Association | 1987 | Yes |
| Selective bronchial blocking in children. | Anaesthesia and intensive care | 1975 | Yes |
Showing 5 of 11 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.